Cochlear Implantation in Neurobrucellosis

Abstract

Background: Neurobrucellosis is a disease consisting of a wide spectrum of complications such as peripheral neuropathy, cranial nerve involvement, ataxia, meningeal irritation, paraplegia, seizures, coma, and even death. The vestibulocochlear nerve seems to be the most commonly affected cranial nerve (10%). We present a patient with neurobrucellosis whose auditory perception and speech intelligibility skill performances improved after cochlear implantation. Case Report: A 35 year-old woman was admitted to another hospital 2 years ago with the symptoms of headache, nausea, and altered consciousness, who was finally diagnosed with neurobrucellosis. She developed bilateral profound sensorineural hearing loss during the following 6 months. There was no benefit of using hearing aids. After successful treatment of her illness, she was found to be suitable for cochlear implantation. After the operation, her auditory perception skills improved significantly with a Categories of Auditory Performance (CAP) score of 5. According to clinical observations and her family members’ statements, her Speech Intelligibility Rating (SIR) score was 3. Her speech intelligibility skills are still improving. Conclusion: Our case report represents the second case of hearing rehabilitation with cochlear implantation after neurobrucellosis. Cochlear implantation is a cost-effective and time-proven successful intervention in post-lingual adult patients with sensorineural hearing loss. Early timing of the surgery after appropriate treatment of meningitis helps the patient to achieve better postoperative results.

Keywords

• Cochlear implantation, neurobrucellosis, sensorineural hearing loss

References

1. 1. Gul H, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis 2009;13:e339-e43. [CrossRef]
2. 2. Kaygusuz TO, Kaygusuz I, Kilic SS, Yalcin S, Felek S. Investigation of hearing loss in patients with acute brucellosis by standard and high-frequency audiometry. Clin Microbiol Infect 2005;11:559-63. [CrossRef]
3. 3. Guven T, Ugurlu K, Ergonul O, Celikbas AK, Gok SE, Comoglu S, et al. Neurobrucellosis: Clinical and Diagnostic Features. Clin Infect Dis 2013;56:1407-2. [CrossRef]
4. 4. Bayazit YA, Namiduru M, Bayazit N, Ozer E, Kanlikama M. Hearing status in brucellosis. Otolaryngol Head Neck Surg 2002;127:97-100. [CrossRef]
5. 5. Uhlmann RF, Larson EB, Rees TS, Koepsell TD, Duckert LG. Relationship of hearing impairment to dementia and cognitive dysfuction in older adults. JAMA 1989;261:1916-9. [CrossRef]
6. 6. Guneri E, Kirkim G, Serbetcioglu B, Erdag T, Guneri A. Cochlear Implantation in Neurobrucellosis. Otol Neurotol 2009;30:747-9. [CrossRef]
7. 7. Lin FR, Chien WW, Lingsheng Li, Niparko JK, Francis HW. Cochlear implantation in older adults. Medicine (Baltimore) 2012;91:229-41. [CrossRef]
8. 8. Gaylor JM, Raman G, Chung M, Lee J, Rao M, Lau J, et al. Cochlear Implantation in Adults: A Systematic Review and Metaanalysis. JAMA Otolaryngol Head Neck Surg 2013;139:265-72. [CrossRef]

9. 9. Buckley K, Tobey E. Cross-Modal Plasticity and Speech Perception in Pre- and Postlingually Deaf Cochlear Implant Users. Ear Hear 2010:1. [CrossRef]